Evidence map›Paper›PMID 39849173›Full record

ArticleJournal of neurology2025

Unleashing creativity in people with Parkinson's disease: a pilot study of a co-designed creative arts therapy.

Blanca T M Spee, Nienke M de Vries, Sara Zeggio, Marjoke Plijnaer, Jan-Jurjen Koksma, Annelien A Duits, Thieme Stap, Gert Pasman, Suzanne Haeyen, Sirwan Darweesh and 3 more

Abstract read
In one paragraph

Article in Journal of neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Towards the Prevention of Freezing of Gait in Parkinson's Disease.The European journal of neuroscience · 2026
    Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Blanca T M SpeeDepartment of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, the Netherlands. blanca.spee@univie.ac.at.ORCID http://orcid.org/0000-0002-0575-5467
Nienke M de VriesDepartment of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, the Netherlands.
Sara ZeggioDepartment of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, the Netherlands.
Marjoke PlijnaerArt Unbound, collaboration partner of Radboud University Medical Center, Nijmegen, the Netherlands.
Jan-Jurjen KoksmaRadboud University Medical Center Health Academy, Nijmegen, the Netherlands.
Annelien A DuitsDepartment of Medical Psychology, Radboud University Medical Centre, Nijmegen, the Netherlands.
Thieme StapRadboud University Medical Center Health Academy, Nijmegen, the Netherlands.
Gert PasmanFaculty of Industrial Design Engineering, Delft University of Technology, Delft, the Netherlands.
Suzanne HaeyenGGNet, Centre of Expertise for Personality Disorders Apeldoorn, Centre for Mental Health, PO Box 2003, Scelta, 7230 GC, Warnsveld, the Netherlands.
Sirwan DarweeshDepartment of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, the Netherlands.
Julia CroneVienna Cognitive Science Hub, University of Vienna, Vienna, Austria.
Bastiaan R BloemDepartment of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, the Netherlands.
Matthew PelowskiVienna Cognitive Science Hub, University of Vienna, Vienna, Austria.

Funding

Austrian Science Fund CM1100-B
6 · The paper itself

Abstract

backgroundConventional medical management, while essential, cannot address all multifaceted consequences of Parkinson's disease (PD). This pilot study explores the potential of a co-designed creative arts therapy on health-related quality of life, well-being, and pertinent non-motor symptoms.

methodsWe conducted an exploratory pilot study with a pre-post design using validated questionnaires. Eight individuals with PD participated in the program. The investigated intervention was a 10-week creative arts therapy with weekly 90-120-min sessions, guided by three creative therapists. Participants were allowed to autonomously select from multiple creative media based on their personal preferences. Explored co-primary outcomes included health-related quality of life (PDQ-39), well-being (ICECAP-A), anxiety/depression (HADS), executive functioning (BRIEF-A), resilience/mental flexibility (FIT-60), and self-efficacy (GSES). We used paired sample t tests for pre-post analysis of the co-primary outcomes and Wilcoxon signed-rank tests for PDQ-39 sub-scores. We also included aesthetic responsiveness (AReA) and healthcare consumption (IMCQ adapted for PD) questionnaires reported as descriptive statistics.

resultsThe results showed a significant reduction in anxiety and an increase in well-being. We also observed a slight improvement in cognitive functioning. Finally, we noted a reduction in healthcare consumption (fewer visits at neurologists, specialized PD nurses, and allied healthcare professionals).

conclusionThese findings cautiously suggest that our co-designed, multi-media creative arts therapy has the potential to increase well-being and reduce anxiety, while reducing healthcare consumption. These preliminary findings support the need for a larger, randomized controlled trial to explore the therapeutic potential of creative arts therapy in PD care.

Indexed as

Art TherapyCreativityParkinson DiseaseQuality of LifeAgedAnxietyFemaleHumansMaleMiddle AgedPilot ProjectsSurveys and QuestionnairesAnxietyArt-based methodsCreative arts therapyParkinson’s diseaseWell-being

Identifiers

PMID39849173
PMCPMC11758163

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.